Effect of ergot alkaloids on serum prolactin in non-psychotic organic brain syndrome of the elderly.
A compound of ergot alkaloids (Hydergine-Sandoz) or placebo was given to sixty elderly nursing home patients with non-psychotic organic brain syndrome. Subsequent to 12 weeks of treatment, the mean serum prolactin of the drug was significantly lower than that of the placebo group. No correlation was found between changes in prolactin and changes in behavior using Sandoz Assessment of Clinical Status Rating Form-Geriatric [SCAG]. It may be that a higher dose of Hydergine with an accompanying greater drop in prolactin would be required to observe this effect.
D000368:Aged; D003704:Dementia / Q000097:blood / Q000188:drug therapy*; D004088:Dihydroergotoxine / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D011388:Prolactin / Q000097:blood*; D013375:Substance Withdrawal Syndrome / Q000097:blood
D004088:Dihydroergotoxine; D011388:Prolactin